Ubc Research Excellence Cluster Coordinator
Matrix-N (Multidisciplinary Alliance For Translational Research And Innovation I
AeroLeads people directory · profile
Lily Aleksandrova Email & Phone Number
UBC Research Excellence Cluster Coordinator
at
MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i
1 work email found
@ubc.ca
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 86%
Role
UBC Research Excellence Cluster Coordinator
Location
Vancouver, British Columbia, Canada
Who is Lily Aleksandrova? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Lily Aleksandrova is listed as UBC Research Excellence Cluster Coordinator at MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i, based in Vancouver, British Columbia, Canada. AeroLeads shows a work email signal at ubc.ca and a matched LinkedIn profile for Lily Aleksandrova.
Lily Aleksandrova previously worked as Postdoctoral Research Fellow at The University Of British Columbia and UBC Research Excellence Cluster Coordinator at Matrix-N (Multidisciplinary Alliance For Translational Research And Innovation In Neuropsychiatry). Lily Aleksandrova holds Bachelor Of Science - Bs (Hon), Double Major In Pharmacology And Human Biology from University Of Toronto.
Company email context
Email format at MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i
This section adds company-level context without repeating Lily Aleksandrova's masked contact details.
{first}.{last}@ubc.ca
86% confidence
AeroLeads found 1 current-domain work email signal for Lily Aleksandrova. Compare company email patterns before reaching out.
Profile bio
About Lily Aleksandrova
As a neuroscience researcher and writer, I look at the intersection of brain, behaviour, and therapeutics through a multidisciplinary lens. I'm a critical and creative thinker who specializes in scientific storytelling, tackling complex research questions, and working in collaborative teams. I am passionate about translational research, science communication, knowledge mobilization, and the development of novel therapeutic approaches to improve mental health. My research investigates the mechanisms of action of promising new therapies for neuropsychiatric disorders. I’m particularly interested in the role of neuroplasticity, the brain’s ability to change through growth and reorganization, in the therapeutic action of breakthrough therapies for depression and substance use disorders, such as ketamine and psychedelics. I am currently a postdoc in the Department of Psychiatry at UBC, working with a private biotech company to facilitate the preclinical and clinical evaluation of a natural health product for opioid withdrawal and pain management. In addition, as a way to maintain a healthy balance of enthusiasm and critical thinking around the emerging therapeutic potential of psychedelics from bench-to-bedside-to-community, I’m a freelance science writer and research advisor for the biotech industry, with a specific focus on psychedelic research.I am also the coordinator for the new UBC Research Excellence Cluster, MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation in Neuropsychiatry). MATRIX-N seeks to bridge gaps between research, clinical practice, and patient needs to facilitate innovative solutions to global mental health challenges. The cluster aims to create new multidisciplinary collaborations between foundational and clinical researchers to increase the translational power of neuropsychiatry research into novel pharmacotherapies and ensure more cost-effective, clinically relevant drug development processes.I have a Master’s degree in Pharmacology and Toxicology from UofT and a PhD in Neuroscience from UBC, as well as 13+ years of research experience in basic neuroscience and clinical research labs. My past research projects investigated breakthrough therapies for depression, particularly ketamine and deep brain stimulation (DBS), in terms of their molecular, neuroplasticity and cognitive effects using preclinical models and a wide range of methodologies (e.g. behavioural neuropsychopharmacology, molecular biology, electrophysiology, neuroimaging, genetics).Contact: lilyraleksandrova@gmail.com
Current workplace
Lily Aleksandrova's current company
Company context helps verify the profile and gives searchers a useful next step.
Matrix-N (Multidisciplinary Alliance For Translational Research And Innovation I
AeroLeads page
13 roles
Lily Aleksandrova work experience
A career timeline built from the work history available for this profile.
Postdoctoral Research Fellow
CurrentDepartment of Psychiatry; Supervisor: Dr. Anthony G. Phillips, working in collaboration with Dr. Michael Krausz, the Addictions and Concurrent Disorders Research Group at UBC and the private biotech company Resilience Biosciences Inc; Project: Preclinical and Clinical Evaluation of a Lead Herbal Formulation To Facilitate Opioid Withdrawal; Assisting with other research projects in the lab, preparing grant applications and manuscripts for submission, published 3 articles to-date.
Apr 2020 - Present
Ubc Research Excellence Cluster Coordinator
Current
Matrix-N (Multidisciplinary Alliance For Translational Research And Innovation In Neuropsychiatry)
MATRIX-N seeks to bridge gaps between research, clinical practice, and patient needs to facilitate innovative solutions to global mental health challenges. The cluster will create new multidisciplinary collaborations between foundational and clinical researchers to increase the translational power of neuropsychiatry research into novel pharmacotherapies (e.g., ketamine, psychedelics) and ensure more cost-effective and clinically-relevant drug development processes.
Apr 2022 - Present
Government Liaison, Research Development And Compliance Officer
Current
Resilience Biosciences Inc.
Working with Dr. Anthony G. Phillips, Dr. Michael Krausz and their research groups at UBC; Project: Preclinical and Clinical Evaluation of the Herbal Formulation TGIR to Facilitate Opioid Withdrawal - Helping prepare research project documentation (grant applications, clinical protocols, business plans, etc.), help in obtaining approval for a clinical trial program to test this natural health product as a supplemental treatment for opioid use disorder.
Apr 2020 - Present
Contributing Writer
Bring cutting-edge psychedelic science to the public in the most accessible, thorough and scientifically accurate way possible. Selected articles:Food for Thought: Can Psychedelics Boost Brain Growth Factor Levels? First Modern Dose-Response Study of LSD Confirms the Critical Role of the Serotonin 2A Receptor Psilocybin and Mindfulness for Depression: Complementary Actions Starting to EmergeKetamine-Induced Brain Rhythm Causes Dissociation: From Mice to Man The Role of… Show more Bring cutting-edge psychedelic science to the public in the most accessible, thorough and scientifically accurate way possible. Selected articles:Food for Thought: Can Psychedelics Boost Brain Growth Factor Levels? First Modern Dose-Response Study of LSD Confirms the Critical Role of the Serotonin 2A Receptor Psilocybin and Mindfulness for Depression: Complementary Actions Starting to EmergeKetamine-Induced Brain Rhythm Causes Dissociation: From Mice to Man The Role of Oxytocin in MDMA’s Prosocial EffectsCrystal Structure of LSD and 5-HT2AR Part 2: Binding Details and Future Psychedelic Research PathsCrystal Structure of LSD and 5-HT2AR- Part 1: Capturing the First Steps of a Psychedelic Trip Show less
May 2020 - Apr 2021
Research Associate / Phd Candidate
UBC Departments of Psychiatry and Neurology; Co-supervisors: Dr. Anthony G. Phillips, Dr. Yu Tian Wang. PhD project: Evaluating the role of glutamate receptors and synaptic plasticity in depression and ketamine antidepressant response using a preclinical model - Awarded UBC Neuroscience 4-year Fellowship, implemented new experimental protocols, conducted thesis research (using behavioural testing, pharmacological treatments, electrophysiology, molecular biology, etc.), led key collaborations… Show more UBC Departments of Psychiatry and Neurology; Co-supervisors: Dr. Anthony G. Phillips, Dr. Yu Tian Wang. PhD project: Evaluating the role of glutamate receptors and synaptic plasticity in depression and ketamine antidepressant response using a preclinical model - Awarded UBC Neuroscience 4-year Fellowship, implemented new experimental protocols, conducted thesis research (using behavioural testing, pharmacological treatments, electrophysiology, molecular biology, etc.), led key collaborations with other labs, trained and mentored students, presented at local and international conferences including being chosen to give a Nanosymposium lecture at the 2018 Society for Neuroscience (SfN) meeting, published five high-impact 1st author articles, generated pilot data for the lab's successful CIHR 5-year project grant Show less
Sep 2014 - Dec 2019
Phd Candidate
PhD Dissertation: Characterization of the Wistar-Kyoto rat model of depression in the context of hippocampal synaptic plasticity and ketamine’s antidepressant response. (2019). University of British Columbia. Co-supervisors: Dr. Anthony G. Phillips, Dr. Yu Tian Wang. Coursework: A+
Sep 2014 - Nov 2019
Msc Student
MSc Dissertation: Pre-clinical Modeling of Treatment-Induced Impulsivity in Parkinson’s disease. (2013). University of Toronto. Co-supervisors: Jose N. Nobrega, Daniella S.S. Lobo. Coursework: A+
Sep 2011 - Sep 2013
Head Teaching Assistant
Department of Pharmacology, UofT; Course: PCL470Y – Systems Pharmacology (core 4th year undergrad course) - Led tutorials and group discussions for ~80 students, held office hours, marked exams and assignments for ~200 students
Sep 2011 - May 2013
Research Assistant / Msc Student
Neuroimaging Research Section; Co-supervisors: Dr. Jose N. Nobrega, Dr. Daniella S.S. Lobo; Master's Research project: Preclinical modeling of treatment-induced impulsivity in Parkinson’s disease - Evaluating the effects of deep brain stimulation (DBS) and dopaminergic agonists - Implemented new lab techniques and protocols, conducted thesis research, trained and mentored students, awarded OPGRC Master’s Fellowship, UofT Pharmacology and Faculty of Medicine Graduate Awards, presented at local… Show more Neuroimaging Research Section; Co-supervisors: Dr. Jose N. Nobrega, Dr. Daniella S.S. Lobo; Master's Research project: Preclinical modeling of treatment-induced impulsivity in Parkinson’s disease - Evaluating the effects of deep brain stimulation (DBS) and dopaminergic agonists - Implemented new lab techniques and protocols, conducted thesis research, trained and mentored students, awarded OPGRC Master’s Fellowship, UofT Pharmacology and Faculty of Medicine Graduate Awards, presented at local and national conferences, published two research articles Show less
Sep 2011 - Sep 2013
Research Assistant
Neuroimaging Research Section; Co-supervisors: Dr. Jose N. Nobrega, Dr. Daniella S.S. Lobo - Conducted behavioural testing, pharmacological experiments and candidate gene analyses in a preclinical model, implemented new techniques, expanded scope of research project, decided to pursue my Master's in the lab
Sep 2010 - Aug 2011
Undergraduate Research Associate
Neurogenetics Research Section; Supervisors: Dr. Daniella S. Lobo, Dr. James L. Kennedy; Research project: Addiction-related Genes in Gambling Disorders - Conducted genetic association study of neuroticism in problem gamblers, designed experiment, performed genotyping on blood samples, analyzed data, published one 1st author article
May 2010 - Sep 2010
Work Study Student
Clinical Research Department; Research Project: Blue Sky Project - Prepared research materials, maintained records of project documentation, performed data entry and statistical analysis
Sep 2009 - Mar 2010
3 education records
Lily Aleksandrova education
Bachelor Of Science - Bs (Hon), Double Major In Pharmacology And Human Biology
Master Of Science - Ms, Pharmacology And Toxicology
Doctor Of Philosophy - Phd, Neuroscience
FAQ
Frequently asked questions about Lily Aleksandrova
Quick answers generated from the profile data available on this page.
What company does Lily Aleksandrova work for?
Lily Aleksandrova works for MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i.
What is Lily Aleksandrova's role at MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i?
Lily Aleksandrova is listed as UBC Research Excellence Cluster Coordinator at MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i.
What is Lily Aleksandrova's email address?
AeroLeads has found 1 work email signal at @ubc.ca for Lily Aleksandrova at MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i.
Where is Lily Aleksandrova based?
Lily Aleksandrova is based in Vancouver, British Columbia, Canada while working with MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i.
What companies has Lily Aleksandrova worked for?
Lily Aleksandrova has worked for Matrix-N (Multidisciplinary Alliance For Translational Research And Innovation I, The University Of British Columbia, Matrix-N (Multidisciplinary Alliance For Translational Research And Innovation In Neuropsychiatry), Resilience Biosciences Inc., and Psychedelic Science Review.
How can I contact Lily Aleksandrova?
You can use AeroLeads to view verified contact signals for Lily Aleksandrova at MATRIX-N (Multidisciplinary Alliance for Translational Research and Innovation i, including work email, phone, and LinkedIn data when available.
What schools did Lily Aleksandrova attend?
Lily Aleksandrova holds Bachelor Of Science - Bs (Hon), Double Major In Pharmacology And Human Biology from University Of Toronto.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialPeople with similar names
Check these profiles if this is not the Lily Aleksandrova you were looking for.
View similar profiles